Nanobiotechnology: Application of nanotechnology in therapeutics and diagnosis

International Journal of Green Nanotechnology: Biomedicine

Volumn 1, Issue 1, 2009, Pages

  Mohanty, Chandana ^a   Arya, Geetanjali ^a   Verma, Rama S ^b   Sahoo, Sanjeeb K ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Nanobiotechnology; Nanotechnology; Therapeutics and diagnosis

Indexed keywords

EID: 77958582400     PISSN: 1943085X     EISSN: 19430906     Source Type: Journal    
DOI: 10.1080/19430850902908522     Document Type: Article

References (86)

1. Sahoo, S. K.; Labhasetwar, V. Nanotech approaches to drug delivery and imaging. Drug Discov. Today 2003, 8, 1112-1120.
2. Sahoo, S. K.; Parveen, S.; Panda, J. J. The present and futute of nanotechnology in human health care. Nanomed. Nanotechnol. Biol. Med. 2007, 3, 20-31.
3. Silva, G. A. Introduction to nanotechnology and its applications to medicine. Surg. Neurol. 2004, 61, 216-20.
4. Roco, M. C. Nanotechnology: Convergence with modern biology and medicine. Curr. Opin. Biotechnol. 2003, 14, 337-46.
5. Thrall, J. H. Nanotechnology and medicine. Radiology 2004, 230, 315-8.
6. Whitesides, G. M. The once and future nanomachine. Sci. Am. 2001, 285, 78-83.
7. Baneyx, G.; Baugh, L.; Vogel, V. Coexisting conformations of fibronectin in cell culture imaged using fluorescence resonance energy transfer. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 14464-14468.
8. Fox, R. F.; Choi, M. H. Rectified Brownian motion and kinesin motion along microtubules. Phys Rev E Stat Nonlin Soft Matter Phys 63, 051901.
9. Davis, A. V.; Yeh, R. M.; Raymond, K. N. Supramolecular assembly dynamics. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 4793-476.
10. Dubertret, B.; Skourides, P.; Norris, D. J.; Noireaux, V.; Brivanlou, A. H.; Libchaber, A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298, 1759-1762.
11. McIntire, L. V. World technology panel report on tissue engineering. Ann. Biomed. Eng. 2002, 30, 1216-1220.
12. Buxton, D. B.; Golomb, E.; Adelstein, R. S. Induction of nonmuscle myosin heavy chain II-C by butyrate in RAW264.7 mousemacrophages. J. Biol. Chem. 2003, 278, 15449-15455.
13. Cui, Y.; Wei, Q.; Park, H.; Lieber, C. M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 2001, 293, 1289-1292.
14. Arayne, M. S.; Sultana, N. Review: Nanoparticles in drug delivery for the treatment of cancer. Pak. J. Pharm. Sci. 2006, 19, 258-268.
15. Dekker, C. Solid-state nanopores. Nat. Nanotechnol. 2007, 2, 209-215.
16. Liu, W.; Frank, J. A. Detection and quantification of magnetically labeled cells by cellular MRI. Eur. J. Radiol. 2008, 70, 258-264.
17. Bulte, J. W.; Kraitchman, D. L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004, 17, 484-499.
18. Schellenberger, E. A.; Hogemann, D.; Josephson, L.; Weissleder, R. Annexin V-CLIO: A nanoparticle for detecting apoptosis by MRI. Acad. Radiol. 2002, 9(Suppl 2), S310-S311.
19. Wunderbaldinger, P.; Josephson, L.; Weissleder, R. Crosslinked iron oxides (CLIO): A new platform for the development of targeted MR contrast agents. Acad. Radiol. 2002, 9(Suppl 2), S304-S306.
20. Mahmood, U.; Tung, C. H.; Tang, Y.;Weissleder, R. Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. Radiology 2002, 224, 446-451.
21. Baldridge, J. R.; Crane, R. T. Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines. Methods 1999, 19, 103-107.
22. Taton, T. A.; Mirkin, C. A.; Letsinger, R. L. Scanometric DNA array detection with nanoparticle probes. Science 2000, 289, 1757-1760.
23. Pancrazio, J. J. Neural interfaces at the nanoscale. Nanomedicine 2008, 3, 823-830.
24. Bruchez, M., Jr.; Moronne, M.; Gin, P.; Weiss, S.; Alivisatos, A. P. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281, 2013-2016.
25. Chan, W. C.; Maxwell, D. J.; Gao, X.; Bailey, R. E.; Han, M.;Nie, S. Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 2002, 13, 40-46.
26. Shah, N.; Cerussi, A.; Eker, C.; Espinoza, J.; Butler, J.; Fishkin, J.; Hornung, R.; Tromberg, B. Noninvasive functional optical spectroscopy of human breast tissue. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 4420-4425.
27. Chan, W. C.; Nie, S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998, 281, 2016-8.
28. Goldman, E. R.; Balighian, E. D.; Mattoussi, H.; Kuno, M. K.; Mauro, J. M.; Tran, P. T.; Anderson, G. P. Avidin: A natural bridge for quantum dot-antibody conjugates. J. Am. Chem. Soc. 2002, 124, 6378-6382.
29. Han, M.; Gao, X.; Su, J. Z.; Nie, S. Quantumdot-tagged microbeads for multiplexed optical coding of biomolecules. Nat. Biotechnol. 2001, 19, 631-635.
30. Mascini, M.; Tombelli, S. Biosensors for biomarkers in medical diagnostics. Biomarkers 2008, 13, 637-657.
31. Jianrong, C.; Yuqing, M.; Nongyue, H.; Xiaohua, W.; Sijiao, L. Nanotechnology and biosensors. Biotechnol. Adv. 2004, 22, 505-18.
32. Richardson, J.; Hawkins, P.; Luxton, R. The use of coated paramagnetic particles as a physical label in a magneto-immunoassay. Biosens. Bioelectron. 2001, 16, 989-993.
33. Chemla, Y. R.; Grossman, H. L.; Poon, Y.; McDermott, R.; Stevens, R.; Alper, M. D.; Clarke, J. Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 14268-14272.
34. Maxwell, D. J.; Taylor, J. R.; Nie, S. Self-assembled nanoparticle probes for recognition and detection of biomolecules. J. Am. Chem. Soc. 2002, 124, 9606-9612.
35. Zhao, J.; Sun, J. [The design and application of small signal clinic sensor.] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2004, 21, 1003-1005.
36. Xu, C.; Cai, H.; Xu, Q.; He, P.; Fang, Y. Characterization of single-stranded DNA on chitosan-modified electrode and its application to the sequence-specific DNA detection. Fresenius J. Anal. Chem. 2001, 369, 428-432.
37. Sahoo, S. K.; Dilnawaz, F.; Krishnakumar, S. Nanotechnology in ocular drug delivery. Drug Discov. Today 2008, 13, 144-151.
38. Panyam, J.; Zhou, W. Z.; Prabha, S.; Sahoo, S. K.; Labhasetwar, V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J. 2002, 16, 1217-1226.
39. Sahoo, S. K.; Ma, W.; Labhasetwar, V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer 2004, 112, 335-340.
40. Parveen, S.; Sahoo, S. K. Polymeric nanoparticles for cancer therapy. J. Drug Target 2008, 16, 108-123.
41. Sahoo, S. K.; Labhasetwar, V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm. 2005, 2, 373-383.
42. El-Shabouri, M. Positively charged nanoparticles for improving the oral bioavailability of cyclosporine-A. Int. J. Pharm. 2002, 249, 101-108.
43. Parveen, S.; Sahoo, S. K. Nanomedicine: Clinical applications of polyethylene glycol conjugated proteins and drugs. Clin. Pharmacokinet. 45, 965-988.
44. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55, 329-347.
45. Lewin, M.; Carlesso, N.; Tung, C. H.; Tang, X. W.; Cory, D.; Scadden, D. T.; Weissleder, R. Tat peptidederivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000, 18, 410-414.
46. Kolodgie, F. D.; John, M.; Khurana, C.; Farb, A.; Wilson, P. S.; Acampado, E.; Desai, N.; Soon-Shiong, P.; Virmani, R. Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation 2002, 106, 1195-1198.
47. Savic, R.; Luo, L.; Eisenberg, A.; Maysinger, D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003, 300, 615-618.
48. Smith, R. A.; Porteous, C.M.; Gane, A.M.; Murphy, M. P. Delivery of bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 5407-5412.
49. Lee, E. S.; Na, K.; Bae, Y. H. Polymeric micelle for tumor pH and folate-mediated targeting. J. Control Release 2003, 91, 103-113.
50. Friedman, S. H.; Ganapathi, P. S.; Rubin, Y.; Kenyon, G. L. Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation. J. Med. Chem. 1998, 41, 2424-2429.
51. Zhu, Z.; Schuster, D. I.; Tuckerman, M. E. Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease. Biochemistry 2003, 42, 1326-1333.
52. Jin, H.; Chen, W. Q.; Tang, X. W.; Chiang, L. Y.; Yang, C. Y.; Schloss, J. V.; Wu, J. Y. Polyhydroxylated C(60), fullerenols, as glutamate receptor antagonists and neuroprotective agents. J. Neurosci. Res. 2000, 62, 600-607.
53. Jiang, W.; Gupta, R. K.; Deshpande, M. C.; Schwendeman, S. P. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Drug Deliv. Rev. 2005, 57, 391-410.
54. O'Hagan, D. T.; Singh, M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev. Vaccines 2003, 2, 269-283.
55. O'Hagan, D. T.; Singh, M.; Ulmer, J. B. Microparticle-based technologies for vaccines. Methods 2006, 40, 10-19.
56. Eldridge, J. H.; Staas, J. K.; Meulbroek, J. A.; Tice, T. R.; Gilley, R. M. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 1991, 59, 2978-2986.
57. Men, Y.; Tamber, H.; Audran, R.; Gander, B.; Corradin, G. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres. Vaccine 1997, 15, 1405-1412.
58. Johansen, P.; Raynaud, C.; Yang, M.; Colston, M. J.; Tascon, R. E.; Lowrie, D. B. Antimycobacterial immunity induced by a single injection of M. leprae sp65-encoding plasmid DNA in biodegradable microparticles. Immunol. Lett. 2003, 90, 81-85.
59. Borges, O.; Borchard, G.; Verhoef, J. C.; de Sousa, A.; Junginger, H. E. Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int. J. Pharm. 2005, 299, 155-166.
60. Jones, L. S.; Peek, L. J.; Power, J.; Markham, A.; Yazzie, B.; Middaugh, C. R. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J. Biol. Chem. 2005, 280, 13406-13414.
61. Ott, G.; Barchfeld, G. L.; Chernoff, D.; Radhakrishnan, R.; van Hoogevest, P.; Van Nest, G. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm. Biotechnol. 1995, 6, 277-296.
62. Frey, S.; Poland, G.; Percell, S.; Podda, A. Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults. Vaccine 2003, 21, 4234-4237.
63. Ulrich, J. T.; Myers, K. R. Monophosphoryl lipid A as an adjuvant. Past experiences and newdirections. Pharm. Biotechnol. 1995, 6, 495-524.
64. Johnson, A. G.; Gaines, S.; Landy, M. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J. Exp. Med. 1956, 103, 225-246.
65. Cox, J. C.; Sjolander, A.; Barr, I. G. ISCOMs and other saponin based adjuvants. Adv. Drug Deliv. Rev. 1998, 32, 247-271.
66. Pearse, M. J.; Drane, D. ISCOMATRIX adjuvant for antigen delivery. Adv. Drug Deliv. Rev. 2005, 57, 465-474.
67. Aucouturier, J.; Dupuis, L.; Deville, S.; Ascarateil, S.;Ganne, V. Montanide ISA 720 and 51: Anewgeneration of water in oil emulsions as adjuvants for human vaccines. Expert Rev Vaccines 2002, 1, 111-118.
68. Scalzo, A. A.; Elliott, S. L.; Cox, J.; Gardner, J.; Moss, D. J.; Suhrbier, A. Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J. Virol. 1995, 69, 1306-1309.
69. Ferber, D. Gene therapy: Safer and virus-free? Science 2001, 294, 1638-1642.
70. Johnson, S. M.; Jans, D. A. Gene therapy: Optimising DNA delivery to the nucleus. Current Drug Targets 2001, 2, 371-399.
71. Wagner, E. Polymer nonviral delivery vehicles. In Encyclopedia Diagnostic Genomics and Proteomics; 2005; pp 1047-1051, Marcel Dekker: New York.
72. Slowing, I. I.; Trewyn, B. G.; Giri, S. V.; Lin, S. Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications Adv. Funct. Mater. 2007, 17, 1225-1236.
73. Kommareddy, S.; Amiji, M. Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathioneresponsive intracellular DNA delivery. Nanomedicine 2007, 3, 32-42.
74. Wartlick, H.; Spankuch-Schmitt, B.; Strebhardt, K.; Kreuter, J.; Langer, K. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. J. Control Release 2004, 96, 483-495.
75. Ramesh, R. Nanoparticle-mediated gene delivery to the lung. Methods Mol. Biol. 2008, 433, 301-31.
76. Zucates, G. T.; Little, S.R.; Anderson, D. G.; Langer, R. Poly(β-amino ester)s for DNA delivery. Isr. J. Chem. 2005, 45, 477-485.
77. Prabha, S.; Labhasetwar, V. Nanoparticle mediated wildtype p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol. Pharm. 2004, 1, 211-219.
78. McBain, S. C.; Yiu, H. H.; Dobson, J. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomed. 2008, 3, 169-180.
79. Weizhong, W.; Chunfang, X.; Hua, W. Use of PEIcoated magnetic iron oxide nanoparticles as gene vectors. J. Huazhong Univ. Sci. Technol. Med. Sci. 2004, 24, 618-620.
80. Langer, R.;Vacanti, J. P. Tissue engineering. Science 1993, 260, 920-926.
81. Fuchs, J. R.; Nasseri, B.A.;Vacanti, J. P. Tissue engineering: A 21st century solution to surgical reconstruction. Ann. Thorac. Surg. 2001, 72, 577-591.
82. Persidis, A. Tissue engineering. Nat. Biotechnol. 1999, 17, 508-510.
83. Sipe, J. D. Tissue engineering and reparative medicine. Ann. N. Y. Acad. Sci. 2002, 961, 1-9.
84. Monteiro-Riviere, N. A.; Inman, A. O.; Zhang, L. W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009, 234, 222-235.
85. Rajagopalan, P.;Wudl, F.; Schinazi, R. F.; Boudinot, F. D. Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob. Agents Chemother. 1996, 40, 2262-2265.
86. Deka, S.; Quarta, A.; Lupo, M. G.; Falqui, A.; Boninelli, S.; Giannini, C.; Morello, G.; De Giorgi, M.; Lanzani, G.; Spinella, C.; Cingolani, R.; Pellegrino, T.; Manna, L. CdSe/CdS/ZnS double shell nanorods with high photoluminescence efficiency and their exploitation as biolabeling probes. J. Am. Chem. Soc. 2009, 131, 2948-2958.